- New Generation BTK Inhibitors in R/R CLL: Resistance Mechanism and Optimizing Sequential Therapies
- Evolving Treatment Landscape: Sequencing Strategies in Late R/R MM
- Real World Oncology: Translating Data to Clinical Practice
- Revolutionizing Cancer Treatment: Exploring CAR T-Cell Therapy in R/R LBCL
- Optimizing Outcomes in Advanced Hodgkin Lymphoma: Current Strategies and Emerging Data
- Real World Oncology: Translating Data to Clinical Practice
- Live Q&A
OncLive® State of the Science Summit™ Hematologic Malignancies
Sofitel New York
45 W 44th St
New York, NY 10036
United States
Tuesday, November 18, 2025
6:00 PM-9:00 PM ET
Complimentary Parking
In-Person Only
Event Chair
Saad Z Usmani, MD, MBA, FACP, FASCO
Memorial Sloan Kettering Cancer Center
IN PARTNERSHIP WITH.png)
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
259 Prospect Plains Rd, Bldg H
Monroe, NJ 08831